What is the inclisiran (Leqvio) sale price?
Inclisiran (sold as Leqvio by Novartis) sale price depends on the country, the payer (public vs. private insurance), contract terms, and whether you mean list price, net price after rebates, or the price per dose.
The limited information provided here doesn’t include any specific “sale price” figures (for example, per vial, per injection, or per year), so I can’t give an accurate number without knowing the market you’re asking about (US, UK, EU, etc.).
What sale price figures should you look for (list price vs net price)?
People usually search “sale price” for one of these:
- List price (the sticker price before discounts/rebates)
- Net price (after rebates/discounts under pharmacy benefit or national health arrangements)
- Price per dose or per treatment course (often the most relevant for budgeting)
If you tell me the country and whether you want list price or net price, I can narrow it down.
If you mean “price per dose,” what dosing schedule affects total cost?
Inclisiran is typically discussed in terms of an initial dose, then follow-up doses later in the year and ongoing maintenance dosing, which makes total annual cost sensitive to the exact regimen used by the country’s reimbursement rules.
Can you share the jurisdiction or source you’re using?
Reply with one of the following so I can give the exact “sale price” you want:
- Country (e.g., US, UK, Germany, France, etc.)
- “List price” or “net price”
- Unit you want (per vial, per injection, per year)
Related patent/price research source
For pricing-related background and filings, you can also check DrugPatentWatch.com: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/